supplementary material – Page 46 – Communicable Diseases Research

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

Research Article

Published on 2021-12-222022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, SARS,

[키워드] 1:1 95% CI access acute respiratory syndrome administration Admission adverse event Analysis anti-cytokine therapy benefit cohort of patient cohort study comparable control group coronavirus COVID-19 demonstrated Dexamethasone discharge Effectiveness Fever Hospitalized hospitalized patient illness incidence Infection inhibitor initial Janus kinase laboratory parameter multicenter multiple comparison not different oxygen support Patient potential risk Program progression randomized trial recruited reduced reduction Registered Respiratory failure Result ruxolitinib safety profile SARS-CoV-2 supplementary material survival tested therapy Treatment was selected with COVID-19
[DOI] 10.1186/s12879-021-06982-z PMC 바로가기 [Article Type] Research Article

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

토 실리 주맙

Research

Published on 2021-12-222022-09-01
Journal: Respiratory Research [Category] 진단,

[키워드] 28-day mortality 95% CI Administered allocation Analysis Clinical outcome clinical outcomes consecutive patient consecutive patients COVID-19 discharge Efficacy evaluated finding FiO2 hospital discharge hospitalized patient hospitalized patients IMPROVE Mortality open open label outcome outcomes PaO PaO₂/FiO₂ Patient Primary outcome progression Prospective Study receiving secondary Secondary outcomes severe COVID-19 significant increase significantly higher significantly lower statistically significant difference supplementary material survival systemic inflammatory marker Tocilizumab usual care usual care alone usual care group WHO with COVID-19
[DOI] 10.1186/s12931-021-01914-6 PMC 바로가기 [Article Type] Research

Preliminary findings on the experiences of care for parents who suffered perinatal bereavement during the COVID-19 pandemic

Research Article

Published on 2021-12-222022-10-28
Journal: BMC Pregnancy and Childbirth [Category] COVID-19, SARS,

Critical appraisal of clinical practice guidelines for the management of COVID-19: protocol for a systematic review

Protocol

Published on 2021-12-222022-10-28
Journal: Systematic Reviews [Category] COVID-19, SARS,

[키워드] acute respiratory disease acute respiratory syndrome AGREE II appraisal CINAHL clinical Clinical practice Clinical practice guideline coronavirus coronavirus disease COVID-19 critical appraisal Descriptive statistics eligible ENhance explain guideline Guideline assessment Healthcare provider identify knowledge lack management network Novel coronavirus Patient care patients with COVID-19 peer-reviewed Primary outcome Prospective protocol provided recommendation researcher review Scottish searched secondary outcome supplementary material systematic review Systematic review protocol therapeutic intervention Web of Science World Health Organization
[DOI] 10.1186/s13643-021-01871-7 PMC 바로가기 [Article Type] Protocol

Students’ age and parental level of education influence COVID-19 vaccination hesitancy

Short Communication

Published on 2021-12-222022-10-31
Journal: European journal of pediatrics [Category] COVID-19, COVID19(2023년), SARS,

Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial

고위험 직업군에서 비활성화된 SARS-CoV-2 백신의 안전성 및 면역원성: 무작위, 병렬, 대조 임상 시험

Randomized Controlled Trial

Published on 2021-12-222022-09-12
Journal: Infectious Diseases of Poverty [Category] Coronavirus, SARS, 임상, 진단,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus Adverse reaction Adverse reactions Analysis ANOVA antibody assigned baseline Chi-square China Chinese city clinical collected Controlled clinical trial Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Data analysis determine dose Endpoint geometric mean geometric mean titer GMT health-care system High-risk occupational population immunization immunogenicity inactivated Inactivated SARS-CoV-2 vaccine Infection injection Injections intention-to-treat ITT live SARS-CoV-2 Logistic regression analysis Mild neutralization Neutralizing antibodies neutralizing antibody participant primary immunogenicity randomization Randomized Randomized controlled trial Randomly receive regimen registry reported Result resulting Safety SARS-CoV-2 SARS-CoV-2 neutralizing antibody SARS-CoV-2 vaccine second dose Seroconversion seroconversion rate seroconversion rates Serum neutralizing antibody severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly significantly lower supplementary material the vaccine three groups Trial vaccination variance was performed were used
[DOI] 10.1186/s40249-021-00924-2 PMC 바로가기 [Article Type] Randomized Controlled Trial

Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis

우간다 시골 지역의 일상적인 말라리아 지표에 대한 코로나19의 영향: 중단된 시계열 분석

Research

Published on 2021-12-202022-10-30
Journal: Malaria Journal [Category] COVID-19, 말라리아,

Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland

Research Article

Published on 2021-12-202022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, SARS,

Six-month follow-up of functional status in discharged patients with coronavirus disease 2019

Observational Study

Published on 2021-12-202022-10-04
Journal: BMC Infectious Diseases [Category] SARS, 임상,

Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study

Observational Study

Published on 2021-12-202022-10-27
Journal: BMC Psychiatry [Category] COVID-19,